| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | Interim CFO | Stock option (Right to Buy) | 15,000 | 17 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 15 Jul 2023 | 0 | $0 | 3 | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | 24 Jul 2023, 16:46 |
| INZY | Inozyme Pharma, Inc. | 17 May 2021 | 1 | $0 | 4 | Interim CFO | 18 May 2021, 16:18 |
| INZY | Inozyme Pharma, Inc. | 17 May 2021 | 0 | $0 | 3 | Interim CFO | 18 May 2021, 16:07 |